Consolidation to continue in pharma industry

Conference

Large pharmaceutical companies will continue to consolidate at a rate of one per year for the next f...

Large pharmaceutical companies will continue to consolidate at a rate of one per year for the next few years, in the view of Samuel Isaly, manager of the Finsbury Worldwide Pharmaceutical trust. Isaly said around 15 big pharmaceutical companies remain in today's global marketplace. "Two decades ago there were 30 or 40 big pharma companies," he said. "Since then groups have assimilated, such as GlaxoSmithKline and AstraZeneca, to make up the 15 or so that remain. "One future takeover proposition that comes to mind is Bristol-Myers Squibb, a weakened company often rumoured to be a target o...